Biopreservation  Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Biopreservation Media, Storage Equipment, Laboratory Consumables, Others), By Application (Cell Therapy, Tissue and Organ Preservation, Stem Cell Preservation, Blood and Blood Products Preservation, Reproductive Cells, Others), By End User (Hospitals and Clinics, Biotechnology and Pharmaceutical Companies, Research Institutes and Academic Laboratories, Contract Research Organizations (CROs), Biobanks, Others) and Region Forecast 2020-2031

Biopreservation Market size was valued at US$ 2,540.0 million in 2024 and  is projected to reach US$ 5,013.1 million by 2031 at a CAGR of 10.2%. The market refers to the industry focused on the development and application of products, technologies, and services that enable the preservation, storage, and transportation of biological samples such as cells, tissues, organs, and other biomaterials. It includes biopreservation media, equipment, and laboratory solutions that help maintain the viability, functionality, and integrity of specimens used in clinical, research, and therapeutic applications.

The market is witnessing steady growth, driven by the rising demand for regenerative medicine, personalized healthcare, and advanced cell and gene therapies. Increasing biobanking activities, coupled with the growing need for safe storage of stem cells, blood products, and genetic material, are fueling adoption. Technological advancements in preservation equipment, along with a surge in chronic diseases requiring cell-based treatments, are further strengthening market expansion. With ongoing innovation and rising investment in healthcare infrastructure, the biopreservation market is positioned for significant development across global research and clinical domains.

Facts & Figures

• In fact, over 1,000 biobanks are currently operating worldwide, serving as key end users of biopreservation products and technologies.
• More than 60% of clinical trials in regenerative medicine rely on cryopreserved cells and tissues to ensure consistency and viability of samples.
• The global stem cell banking sector stores over 7 million cord blood and cord tissue units, driving steady demand for preservation media and storage equipment.
• Cell and gene therapy clinical trials exceed 2,000 globally, with a majority requiring advanced preservation solutions for patient-derived materials.
• Automated cryogenic storage systems can store over 10 million biological samples in a single large-scale facility, highlighting the scalability of advanced biopreservation infrastructure.
• Research indicates that cryoprotective agents can improve cell survival rates by up to 80–90%, significantly enhancing the success of regenerative treatments and transplants.

Key Development

• In April 2025, BioLife Solutions, Inc., a leading provider of bioproduction products and services for the cell and gene therapy sector, announced the acquisition of PanTHERA CryoSolutions, Inc., a privately held company specializing in innovative cryopreservation solutions. PanTHERA is recognized for its proprietary Ice Recrystallization Inhibitor technology, which enhances the preservation of biological materials. This acquisition strengthens BioLife Solutions’ portfolio by integrating advanced cryopreservation innovations to support the growing needs of the cell and gene therapy market.

Biopreservation Market Segmentation

Based on the product type

• Biopreservation Media
• Storage Equipment
• Laboratory Consumables
• Others

Among product types, biopreservation media is anticipated to lead the market, driven by its critical role in maintaining the functionality, stability, and viability of biological samples during storage and transportation. Unlike equipment or consumables, preservation media directly impacts the quality of cells, tissues, and genetic material, making it indispensable in regenerative medicine, stem cell research, and biobanking. The increasing demand for cell and gene therapies has intensified the need for advanced cryoprotective agents and specialized formulations that ensure optimal sample integrity. As research and clinical applications expand, biopreservation media stands out as the key enabler of successful biological preservation.

Based on the application

• Cell Therapy
• Tissue and Organ Preservation
• Stem Cell Preservation
• Blood and Blood Products Preservation
• Reproductive Cells
• Others

Among applications, cell therapy is anticipated to lead the market, as it represents one of the fastest-growing areas in modern healthcare and biotechnology. Cell therapy relies heavily on the preservation of living cells to ensure their viability, potency, and safety during storage, transportation, and clinical use. The rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and autoimmune conditions has accelerated the demand for innovative cell-based treatments. Biopreservation plays a vital role in maintaining therapeutic efficacy, particularly for stem cell and immune cell therapies. With increasing clinical trials, expanding regulatory approvals, and heavy investment in regenerative medicine, cell therapy stands out as the dominant application driving market growth.

Based on the end user

• Hospitals and Clinics
• Biotechnology and Pharmaceutical Companies
• Research Institutes and Academic Laboratories
• Contract Research Organizations (CROs)
• Biobanks
• Others

Among end users, biobanks are anticipated to lead the market, owing to their central role in storing, managing, and distributing biological samples for both clinical and research purposes. Biobanks provide critical infrastructure for preserving stem cells, tissues, blood, and genetic material, which are increasingly essential for drug discovery, personalized medicine, and disease research. The growing emphasis on large-scale sample collection for genomic studies, population health programs, and clinical trials has significantly expanded the demand for advanced preservation solutions. Supported by government funding, academic partnerships, and technological advancements in cryogenic storage, biobanks continue to be the most influential end-user segment, driving overall market adoption.